Journal of the Pancreas Open Access

  • ISSN: 1590-8577
  • Journal h-index: 82
  • Journal CiteScore: 35.06
  • Journal Impact Factor: 24.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Abstract

Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)

Ming Yim*

An intraductal papillary mucinous neoplasm (IPMN) is a benign pancreatic cyst that can turn malignant, or cancerous, in the ducts of your pancreas. Not all of these tumours develop into cancer. However, experts believe IPMNs are to blame for pancreatic cancer incidences. Surgery is used to treat malignant IPMNs. IPMNs are pancreatic cystic neoplasms that form within the pancreatic ducts and produce mucin. Because they have the potential to become malignant, it is critical to diagnose and treat them as soon as possible.

IPMNs in the pancreas' head or uncinate process are often removed via the Whipple surgery (pancreaticoduodenectomy). In rare cases if the intraductal papillary mucinous tumour encompasses the entire length of the pancreas, a total pancreatectomy (removal of the entire gland) may be indicated

Published Date: 2022-11-10; Received Date: 2022-10-19